VANGUARD GROUP INC - CO-DIAGNOSTICS INC ownership

CO-DIAGNOSTICS INC's ticker is CODX and the CUSIP is 189763105. A total of 57 filers reported holding CO-DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CO-DIAGNOSTICS INC
ValueSharesWeighting
Q3 2023$1,888,160
-4.5%
1,781,2830.0%0.00%
Q2 2023$1,977,224
-25.0%
1,781,2830.0%0.00%
Q1 2023$2,636,299
-41.3%
1,781,2830.0%0.00%
Q4 2022$4,488,833
-12.8%
1,781,283
+11.0%
0.00%
Q3 2022$5,150,000
-54.6%
1,604,356
-20.7%
0.00%
Q2 2022$11,351,000
-1.9%
2,023,232
+8.1%
0.00%
Q1 2022$11,568,000
-27.8%
1,871,914
+4.3%
0.00%
Q4 2021$16,030,000
-8.4%
1,795,057
-0.2%
0.00%
Q3 2021$17,492,000
+14.7%
1,797,790
-2.8%
0.00%
Q2 2021$15,251,000
-12.7%
1,848,637
+1.0%
0.00%
Q1 2021$17,463,000
+16.3%
1,830,474
+13.4%
0.00%
Q4 2020$15,010,000
-24.5%
1,613,884
+10.3%
0.00%
-100.0%
Q3 2020$19,881,000
-21.1%
1,462,920
+12.3%
0.00%0.0%
Q2 2020$25,198,000
+325.5%
1,302,263
+67.6%
0.00%
Q1 2020$5,922,000
+1019.5%
777,201
+31.5%
0.00%
Q4 2019$529,000
-13.1%
591,0550.0%0.00%
Q3 2019$609,000
+116.7%
591,055
+73.8%
0.00%
Q2 2019$281,000
+88.6%
340,175
+142.1%
0.00%
Q1 2019$149,000
+101.4%
140,490
+180.4%
0.00%
Q4 2018$74,000
-70.5%
50,098
-47.5%
0.00%
Q3 2018$251,000
-19.6%
95,342
+18.7%
0.00%
Q2 2018$312,000
+339.4%
80,315
+146.6%
0.00%
Q1 2018$71,000
-13.4%
32,571
+8.5%
0.00%
Q4 2017$82,00030,0120.00%
Other shareholders
CO-DIAGNOSTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Advisor Resource Council 263,358$1,628,0000.49%
SummerHaven Investment Management, LLC 114,800$709,0000.40%
Prairiewood Capital, LLC 59,145$366,0000.26%
Aristides Capital LLC 60,000$371,0000.23%
EASTERLY INVESTMENT PARTNERS LLC 142,190$879,0000.07%
AXS Investments LLC 24,980$154,0000.06%
Physician Wealth Advisors, Inc. 40,375$188,0000.05%
HUSSMAN STRATEGIC ADVISORS, INC. 36,000$222,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,800$1,742,0000.03%
SUMMIT WEALTH & RETIREMENT PLANNING, INC. 14,248$88,0000.03%
View complete list of CO-DIAGNOSTICS INC shareholders